Python stays far ahead; C strengthens at #2, Java edges past C++, C# is 2025’s winner; Delphi returns, R holds #10.
Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for the ...
TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback